Though Tim Chiang meaningfully scales back his target expectations, he still sees 60% potential upside for PTGX shares thanks to its tech platform.
It’s a short and dramatic plunge for Protagonist Therapeutics Inc (NASDAQ:PTGX). Today, the drug maker’s shares lost nearly 60% of their value after the company’s PROPEL …
It’s a very rewarding trading day for investors in Protagonist Therapeutics Inc (NASDAQ:PTGX) with shares up over 40%, making the stock Wall Street’s …
